COMMUNIQUÉS West-GlobeNewswire

Sales of Olainfarm in November Shrink by 10%
21/12/2017
Olaine, 2017-12-21 07:59 CET (GLOBE NEWSWIRE) -- November 2017, consolidated sales Sales, thsnd. EUR Changes to November 2016 Share in total sales Russia 3 563 -33% 35% Latvia 2 643 5% 26% Ukraine 1 542 209% 15% Belarus [...]
Basilea reports that ceftobiprole received QIDP designation from U.S. FDA for the treatment of Staphylococcus aureus bacteremia (SAB)
21/12/2017
Basel, Switzerland, December 21, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the U.S. Food and Drug Administration (FDA) designated its investigational drug ceftobiprole as a Qualified Infectious [...]
ABLYNX ANNOUNCES POSITIVE DATA FROM ITS JAPANESE ETHNO-BRIDGING STUDY OF CAPLACIZUMAB
21/12/2017
Comparable pharmacokinetics (PK) observed in Japanese and Caucasian healthy volunteers Caplacizumab was well-tolerated in all groups GHENT, Belgium, 21 December 2017 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] [...]
Cannabis Wheaton Income Corp. Announces New Joint Venture for Development of World's Largest Indoor Cannabis Facility with Licensed Producer Partner FV Pharma Inc.
21/12/2017
VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or "Wheaton" or the " Company ") is pleased to announce that it has [...]
Denali Therapeutics Announces Advancement and Expansion of Its LRRK2 Inhibitor Clinical Program for Parkinson’s Disease
20/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases [...]
Apellis Finalizes Phase 3 Clinical Trial Plans for Geographic Atrophy Treatment with APL-2
20/12/2017
CRESTWOOD, Ky. and CAMBRIDGE, Ma., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Kraig Biocraft Laboratories posts Holiday Letter to Shareholders
20/12/2017
ANN ARBOR, Mich., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, announced that the Company posted a Letter to its [...]
Kalytera Therapeutics, Inc. Announces Closing of Brokered Private Placement
20/12/2017
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANCISCO and TEL AVIV, [...]
Aeterna Zentaris Announces FDA Approval of Macrilen™ (macimorelin) for Diagnosis of Adult Growth Hormone Deficiency
20/12/2017
CHARLESTON, S.C., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ), a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical therapies, announced [...]
HMS to Present at the J.P. Morgan 36th Annual Healthcare Conference
20/12/2017
IRVING, Texas, Dec. 20, 2017 (GLOBE NEWSWIRE) -- HMS Holdings Corp (NASDAQ: HMSY ) today announced that Bill Lucia, Chairman and CEO, will make a presentation at the J.P. Morgan 36th Annual Healthcare Conference at 8:30 [...]
The Cooper Companies Sets Annual Meeting and Stockholder Record Dates
20/12/2017
PLEASANTON, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that it will hold its next annual meeting of stockholders on Monday, March 19, 2018. Stockholders of record [...]
Mersana Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
20/12/2017
CAMBRIDGE, Mass., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
AMAG Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference
20/12/2017
WALTHAM, Mass., Dec. 20, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that William Heiden, president and chief executive officer, will present at the 36 th Annual J.P. Morgan [...]
Tabula Rasa HealthCare Subsidiary Partners with The Health Plan of San Mateo to deliver Comprehensive Medication Management Services
20/12/2017
MOORESTOWN, N.J., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ) previously announced that its subsidiary, SinfoníaRx, Inc., has partnered with The Health Plan of San Mateo ( [...]
Helomics® Corporation and Ariel Precision Medicine, Inc. sign a services agreement to Advance Clinical Genomics in Precision Medicine Applications
20/12/2017
PITTSBURGH, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and [...]
Procter & Gamble Present Donation to American College of Prosthodontists Education Foundation
20/12/2017
Chicago, Dec. 20, 2017 (GLOBE NEWSWIRE) -- P&G Crest Oral-B continue their legacy of supporting the dental specialty of prosthodontics by donating a total of $80,000 in 2017 to the American College of [...]
CORRECTION - Achillion Pharmaceuticals, Inc.
20/12/2017
NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- In the news release issued earlier today by Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ), please be advised the headline should read "Achillion Initiates Phase I [...]
Adherium Highlights Milestones Achieved in Advance of 2018
20/12/2017
SAN MATEO, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today highlighted milestones achieved in advance of 2018. “As we [...]
Sensorion to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018
20/12/2017
MONTPELLIER, France, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN / PEA-PME eligible), a biotech company pioneering novel treatments of inner ear diseases, today announced that its senior management [...]

Pages